Results 71 to 80 of about 13,429 (224)

H7N9 influenza A virus in turkeys in Minnesota

open access: yesJournal of General Virology, 2015
Introductions of H7 influenza A virus (IAV) from wild birds into poultry have been documented worldwide, resulting in varying degrees of morbidity and mortality. H7 IAV infection in domestic poultry has served as a source of human infection and disease.
Lebarbenchon, Camille   +15 more
openaire   +3 more sources

Avian influenza overview June–August 2026

open access: yesEFSA Journal, Volume 24, Issue 9, September 2026.
Abstract Between 5 June and 28 August 2026, 110 highly pathogenic avian influenza (HPAI) A(H5N1) virus detections were reported in domestic (7) and wild (103) birds in 12 countries in Europe. The number of detections remained at a seasonal low throughout the summer, continuing the decline observed since spring.
European Food Safety Authority (EFSA)   +16 more
wiley   +1 more source

Isolation and characteristic analysis of a novel strain H7N9 of avian influenza virus A from a patient with influenza-like symptoms in China

open access: yesInternational Journal of Infectious Diseases, 2015
A novel H7N9 virus (A/Changsha/1/2013(H7N9)) identified through routine examination in the influenza network laboratory was analyzed retrospectively.
Faming Chen   +10 more
doaj   +1 more source

CD4+ T‐cell responses directed towards A/H5N1‐derived haemagglutinin peptides increase in patients with seasonal influenza A virus infection

open access: yesClinical &Translational Immunology, Volume 15, Issue 8, 2026.
Abstract Objectives Recent outbreak of influenza A/H5N1 viral infections in birds and mammals worldwide prompted renewed concerns over an emerging H5N1‐related influenza pandemic in the generally immunologically‐naive global population. Cross‐reactive CD4+ T cells between A/H1N1 and A/H5N1 subtypes targeting internal and surface influenza proteins have
Lilith F Allen   +14 more
wiley   +1 more source

Novel pathogenic characteristics of highly pathogenic avian influenza virus H7N9: viraemia and extrapulmonary infection

open access: yesEmerging Microbes and Infections, 2020
The H7N9 virus mutated in 2017, resulting in new cases of highly pathogenic avian influenza (HPAI) H7N9 virus infection. H7N9 was found in a viraemic patient in Guangdong province, China.
Xiao-Xin Wu   +13 more
doaj   +1 more source

Counteracting Influenza Virus Evolution Through the Full Spectrum of Broadly Protective Antibodies

open access: yesImmunological Reviews, Volume 341, Issue 1, August 2026.
ABSTRACT Despite the presence of licensed vaccines and therapeutics, influenza viruses remain a major public health concern, as they cause seasonal respiratory infections and pose a pandemic threat through the emergence of zoonotic strains. Although neutralizing antibodies elicited by seasonal vaccination constitute a primary defense against infection,
Yu Adachi, Yoshimasa Takahashi
wiley   +1 more source

The Comparison between H5N1, H1N1 and H7N9.

open access: yes, 2014
The Comparison between H5N1, H1N1 and H7N9.
Biao Zhu (422476)   +15 more
core   +1 more source

H7N9 influenza: The emerging infectious disease

open access: yesNorth American Journal of Medical Sciences, 2013
Influenza virus infection is a common respiratory pathogen. Emerging of new atypical influenza is usually a big public health threat. H7N9 bird flu is the newest atypical influenza virus infection that has just been reported since early 2013. The emerging of this new disease occurred in China and becomes the present focus for possible worldwide ...
openaire   +3 more sources

Exosome‐Mediated Delivery of PROTACs for Targeted Protein Degradation in Cancer, Neurodegenerative, Infectious, and Inflammatory Diseases

open access: yesJournal of Cellular and Molecular Medicine, Volume 30, Issue 15, August 2026.
ABSTRACT Proteolysis‐targeting chimeras (PROTACs) are heterobifunctional molecules that hijack the ubiquitin‐proteasome system to drive catalytic, sub‐stoichiometric degradation of disease‐associated proteins, offering a mechanistic advantage over occupancy‐driven inhibitors and access to ‘undruggable’ targets.
Sruti Bagchi Ghosh   +9 more
wiley   +1 more source

Poor responses to oseltamivir treatment in a patient with influenza A (H7N9) virus infection

open access: yesEmerging Microbes and Infections, 2013
In March 2013, the cases of human infection with influenza A of H7N9 subtype were first reported. Preliminary data suggested that the H7N9 isolates are sensitive to neuraminidase inhibitors, such as oseltamivir, which is the recommended choice of ...
Xuhui Liu   +5 more
doaj   +1 more source

Home - About - Disclaimer - Privacy